Skip to main content

Calcium in Hyperkalemia..all what you need to know

Generally, calcium is administered to hyperkalemic patients to stabilize the cardiac myocytes by restoring their normal resting membrane potential (Fisch, 1973).

It is generally reserved for moderate to severely hyperkalemic patients with cardiac instability. Although there are no clear guidelines or evidence demonstrating the exact point to administer calcium, many clinicians will administer it if:

 (1) the EKG shows evidence of cardiac destabilization such as widening QRS or loss of p-waves on EKG (be advised that EKG findings in patients with hyperkalemia can vary from patient to patient, and patients with severely elevated serum potassium levels may not manifest concomitant EKG findings); 

(2) Serum potassium levels above 6.5-7mEq/L regardless of the presence of EKG changes

(3) rapid rises in serum potassium levels. 

As a general rule, however, have a low threshold to administer calcium.

There are two options when administering calcium: calcium gluconate and calcium chloride.
Both types of calcium work relatively quickly in restabilizing the cardiac myocyte membrane, within 3-5 minutes.

Calcium chloride contains three times the concentration of calcium compared to calcium gluconate. Therefore, 1gm of calcium chloride is approximately equivalent to 3gm of Calcium gluconate.

Calcium chloride does not need metabolism by the liver in order to be bioavailable to cardiac myocytes, and thus is the preferred method of administration in patients with liver failure, cardiac arrest, or in shock states.
  Calcium chloride, however, does pose a very serious risk for the development of tissue necrosis if it extravasates into the surrounding tissue (Semple, 1996). Therefore, it must be administered via a central venous line or a large bore, well-placed peripheral line.

  Calcium gluconate, however, can be administered through a small peripheral IV if needed, as its risk of tissue necrosis is much less. Patients should be on a cardiac monitor when receiving calcium infusions.

Circulation. 1973 Feb;47(2):408-19.
1996 Jan;51(1):93
Labels:

Comments

Post a Comment

Popular posts from this blog

power injectable peripherally inserted central catheters

Clinical experience with power injectable peripherally inserted central catheters in intensive care patients     Introduction In intensive care units (ICU), peripherally inserted central catheters (PICC) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome by the use of power-injectable catheters . Method We have retrospectively reviewed all the power injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. Results We have collected 89 power injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related blood stream infection. Non-infective complications ...
1 comment
Read more

The 12 decision making steps for post dural puncture headache treatment

Treatment decision-making algorithm for postdural puncture headache. 1. When diagnosis is made, all patients should receive supportive measures (reassurance, bed rest, analgesics, hydration, quiet environment). 2. Severity of symptoms should be classified using VAS scale (mild 1–3, moderate 4–6, severe 7–10). 3. Virtually all patients will improve in time even without additional therapy. (dashed lines) 4. Symptoms worsen or fail to resolve within 5 days. 5. Patient preference dictates the choice between pharmacologic (less effective) and epidural blood patch (EBP). 6. In patients with severe symptoms, EBP is strongly suggested. 7. The most common pharmacologic measure is  caffeine  prescription. 8. The failure, worsening, or recurrence of symptoms after pharmacologic measures favors the use of EBP. 9. In addition to EBP, other epidural treatment options can be considered in select patients (eg,  dextran , saline). 10. A period of 24 h should lapse before repeating EBP. 11...
1 comment
Read more

Things to Avoid in Anesthesia for Pregnant with Pulmonary hypertension

Anesthesia for Pregnant woman with Pulmonary Hypertension is a real challenge for anesthesiologist. It is very crucial to remember the pathophysiology of pulmonary hypertension in pregnant women and to avoid some practices that will worsen the cardiac status. 1-Avoid single shot spinal anesthesia. Some authorities consider pulmonary hypertension as absolute contraindication for single shot spinal anesthesia specially in patients with NYHA III ,IV. Spinal anesthesia causes major hemodynamic instability(decrease SVR, decrease VR, decrease in CO) The preferred neuroaxial techniques are (epidural anesthesia and CSE with minimal spinal dose) 2-Avoid PAC. Pulmonary Artery catheters insertion may lead to pulmonary artery rupture or thrombosis. TEE is better cardiac monitor/Arteial line is mandatory. 3-Avoid Nitrous oxide in gas mixture.N2O increase the PVR 4-If MV to be started, avoid High TV and PEEP 5-Avoid Oxytocin Boluses, or rapid administration of Pitocin. Oxytocin causes ...
Post a Comment
Read more